SHC vs STE
SHC: A global sterilization and lab testing partner ensuring the safety of medical devices and pharmaceuticals for 40+ top-50 device makers and 9 of top-10 pharma companies. STE: STERIS is a global provider of infection prevention and procedural care products and services that help healthcare and life science organizations create a safer, healthier world.
Side-by-side fundamentals
| Metric | SHC | STE | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $17.29 | $210.57 | |
| Market cap as of 2026-07-23 | $4.9B | $20.6B | |
| P/E as of 2026-07-23 | 41.86 | 26.28 | STE lower |
| PEG as of 2026-07-23 | 3.82 | 1.00 | STE lower |
| Net margin as of 2026-07-23 | +9.9% | +13.2% | STE higher |
| Gross margin as of 2026-07-23 | +55.3% | +44.3% | SHC higher |
| Operating margin as of 2026-07-23 | +29.0% | +18.5% | SHC higher |
| ROE as of 2026-07-23 | +20.6% | +11.1% | SHC higher |
| ROA as of 2026-07-23 | +3.6% | +7.4% | STE higher |
| Debt / equity as of 2026-07-23 | 3.59 | 0.27 | STE lower |
| Revenue growth (YoY) as of 2026-07-23 | +7.4% | +8.7% | STE higher |
| Revenue CAGR (3y) SEC XBRL | +5.1% | +9.4% | STE higher |
| Dividend yield as of 2026-07-23 | n/a | +1.2% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 1.78 | 0.93 | |
| 1-year return as of 2026-07-22 close | +52.2% | -5.9% | SHC higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.